Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Massachusetts
Biotech
New Merck KGaA in-office requirement could lead to 70 US layoffs
Employees living more than 50 miles from EMD Serono's Massachusetts R&D site must decide whether to relocate or be laid off.
Darren Incorvaia
Jul 13, 2026 2:32pm
Fierce Pharma
Thermo Fisher winds down Boston area plant
Feb 2, 2026 12:22pm
Pharma's 'urgent need for reinvention': PwC's call to action
Jan 8, 2026 6:00am
Former Abiomed CEO launches bid for Massachusetts governor
Oct 1, 2025 4:00pm
Massachusetts most impacted by NIH research cuts: Grant Witness
Sep 18, 2025 9:38am
Fierce Pharma
Massachusetts shed R&D, manufacturing workers in '24: report
Aug 27, 2025 9:34am